BNP Paribas Financial Markets’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-6,252
| Closed | -$606K | – | 3838 |
|
2019
Q3 | $606K | Sell |
6,252
-14,585
| -70% | -$1.41M | ﹤0.01% | 1537 |
|
2019
Q2 | $2.13M | Buy |
20,837
+13,531
| +185% | +$1.39M | ﹤0.01% | 994 |
|
2019
Q1 | $832K | Buy |
7,306
+5,654
| +342% | +$644K | ﹤0.01% | 1310 |
|
2018
Q4 | $64.7K | Sell |
1,652
-779
| -32% | -$30.5K | ﹤0.01% | 1932 |
|
2018
Q3 | $133K | Buy |
2,431
+189
| +8% | +$10.3K | ﹤0.01% | 1953 |
|
2018
Q2 | $186K | Sell |
2,242
-3,603
| -62% | -$298K | ﹤0.01% | 1868 |
|
2018
Q1 | $389K | Buy |
5,845
+50
| +0.9% | +$3.33K | ﹤0.01% | 1847 |
|
2017
Q4 | $298K | Buy |
5,795
+2,661
| +85% | +$137K | ﹤0.01% | 2127 |
|
2017
Q3 | $279K | Buy |
3,134
+223
| +8% | +$19.9K | ﹤0.01% | 2014 |
|
2017
Q2 | $174K | Buy |
2,911
+2,449
| +530% | +$146K | ﹤0.01% | 2171 |
|
2017
Q1 | $24.6K | Sell |
462
-249
| -35% | -$13.3K | ﹤0.01% | 2480 |
|
2016
Q4 | $35.5K | Sell |
711
-943
| -57% | -$47.1K | ﹤0.01% | 2509 |
|
2016
Q3 | $99.3K | Buy |
1,654
+962
| +139% | +$57.8K | ﹤0.01% | 2107 |
|
2016
Q2 | $35.4K | Buy |
+692
| New | +$35.4K | ﹤0.01% | 2408 |
|
2016
Q1 | – | Sell |
-2,128
| Closed | -$96.4K | – | 3305 |
|
2015
Q4 | $96.4K | Buy |
2,128
+290
| +16% | +$13.1K | ﹤0.01% | 2358 |
|
2015
Q3 | $76.7K | Buy |
1,838
+1,041
| +131% | +$43.4K | ﹤0.01% | 2559 |
|
2015
Q2 | $48K | Buy |
797
+606
| +317% | +$36.5K | ﹤0.01% | 2517 |
|
2015
Q1 | $14.8K | Buy |
+191
| New | +$14.8K | ﹤0.01% | 2529 |
|